본문 바로가기
KERD
논문KCI 등재

Evidence of Placental Villous Inflammation and Apoptosis in Third-Trimester Symptomatic SARS-CoV-2 Maternal Infection

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: In view of conflicting reports on the ability of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to infect placental tissue, this study aimed to further evaluate the impact of inflammation and placental damage from symptomatic third trimester maternal COVID-19 infection. Materials and Methods: This case-control study included 32 placenta samples each from symptomatic COVID-19 pregnancy and normal non-COVID-19 pregnancy. The villous placental area’s inflammatory expression [angiotensin converting enzyme-2 (ACE-2), transmembrane protease serine-2 (TMPRSS2), interferon-γ (IFN-γ), interleukin-6 (IL-6), and SARS-CoV-2 spike protein] and apoptotic rate were examined using immunohistochemistry and Terminal deoxynucleotidyl transferase dUTP Nick- End La beling (TUNEL) assay. Comparison and correlation analysis were used based on COVID-19 infection, placental SARS-CoV-2 spike protein evidence, and maternal severity status. Results: Higher expressions of TMPRSS2, IFN-γ, and trophoblast apoptotic rate were observed in the COVID-19 group (p<0.001), whereas ACE-2 and IL-6 expressions were not significantly different from the control group (p>0.05). Additionally, SARS-CoV-2 spike protein was detected in 8 (25%) placental samples of COVID-19 pregnancy. COVID-19 subgroup analysis revealed in creased IFN-γ, trophoblast, and stromal apoptosis (p<0.01). Moreover, the results of the current study revealed no correlation be tween maternal COVID-19 severity and placental inflammation as well as the apoptotic process. Conclusion: The presence of SARS-CoV-2 spike protein as well as altered inflammatory and apoptotic processes may indicate the presence of placental disturbance in third-trimester maternal COVID-19 infection. The lack of correlation between placental dis ruption and maternal severity status suggests the need for more research to understand the infection process and any potential long-term impacts on all offsprings born to COVID-19-infected pregnant women.

Abstract

Purpose: In view of conflicting reports on the ability of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to infect placental tissue, this study aimed to further evaluate the impact of inflammation and placental damage from symptomatic third trimester maternal COVID-19 infection. Materials and Methods: This case-control study included 32 placenta samples each from symptomatic COVID-19 pregnancy and normal non-COVID-19 pregnancy. The villous placental area’s inflammatory expression [angiotensin converting enzyme-2 (ACE-2), transmembrane protease serine-2 (TMPRSS2), interferon-γ (IFN-γ), interleukin-6 (IL-6), and SARS-CoV-2 spike protein] and apoptotic rate were examined using immunohistochemistry and Terminal deoxynucleotidyl transferase dUTP Nick- End La beling (TUNEL) assay. Comparison and correlation analysis were used based on COVID-19 infection, placental SARS-CoV-2 spike protein evidence, and maternal severity status. Results: Higher expressions of TMPRSS2, IFN-γ, and trophoblast apoptotic rate were observed in the COVID-19 group (p<0.001), whereas ACE-2 and IL-6 expressions were not significantly different from the control group (p>0.05). Additionally, SARS-CoV-2 spike protein was detected in 8 (25%) placental samples of COVID-19 pregnancy. COVID-19 subgroup analysis revealed in creased IFN-γ, trophoblast, and stromal apoptosis (p<0.01). Moreover, the results of the current study revealed no correlation be tween maternal COVID-19 severity and placental inflammation as well as the apoptotic process. Conclusion: The presence of SARS-CoV-2 spike protein as well as altered inflammatory and apoptotic processes may indicate the presence of placental disturbance in third-trimester maternal COVID-19 infection. The lack of correlation between placental dis ruption and maternal severity status suggests the need for more research to understand the infection process and any potential long-term impacts on all offsprings born to COVID-19-infected pregnant women.

참고문헌 (40)

  1. Cascella M, "Features, evaluation, and treatment of coronavirus (COVID-19)" (2023), StatPearls Publishing;
  2. Ioannidis JPA, "The end of the COVID-19 pandemic", Eur J Clin Invest, 52, pp.e13782~ (2022)
  3. Ellington S, "Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020", MMWR Morb Mortal Wkly Rep, 69, pp.769~775 (2020)
  4. Joshi B, "The placental pathology in coronavirus disease 2019 infected mothers and its impact on pregnancy outcome", Placenta, 127, pp.1~7 (2022)
  5. Rebutini PZ, "Association between COVID-19 pregnant women symptoms severity and placental morphologic features", Front Immunol, 12, pp.685919~ (2021)
  6. Hecht JL, "SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology : a series of 19 placentas from COVID-19-positive mothers", Mod Pathol, 33, pp.2092~2103 (2020)
  7. Hosier H, "SARS-CoV-2 infection of the placenta", J Clin Invest, 130, pp.4947~4953 (2020)
  8. Algarroba GN, "Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy", Am J Obstet Gynecol, 223, pp.275~278 (2020)
  9. Patanè L, "Vertical transmission of coronavirus disease 2019 : severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth", Am J Obstet Gynecol MFM, 2, pp.100145~ (2020)
  10. Ouyang Y, "Term human placental trophoblasts express SARS-CoV-2 entry factors ACE2, TMPRSS2, and furin", mSphere, 6, pp.e00250-21~ (2021)
  11. Das¸ T, "Evaluation of postmortem pathological changes in the lung in SARS-CoV-2 RT-PCR positive cases", J Surg Med, 5, pp.1113~1120 (2021)
  12. Soullane S, "Association of placental pathology and gross morphology with autism spectrum disorders", Autism Res, 15, pp.531~538 (2022)
  13. World Health Organization, "COVID-19 clinical management: living guidance, 25 January 2021", World Health Organization, ~ (2021)
  14. Remmele W, "Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue", Pathologe, 8, pp.138~140 (1987)
  15. Wardhana MP, "L-arginine protective effect on systemic blood pressure and placental expression of endoglin, transforming growth factor-β1 in the preeclampsia mice model", Int J Women’s Health Reprod Sci, 9, pp.29~34 (2021)
  16. Kokawa K, "Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium", Hum Reprod, 16, pp.2211~2218 (2001)
  17. Di Mascio D, "Outcome of coronavirus spectrum infections(SARS, MERS, COVID-19)during pregnancy : a systematic review and meta-analysis", Am J Obstet Gynecol MFM, 2, pp.100107~ (2020)
  18. Mullins E, "Coronavirus in pregnancy and delivery : rapid review", Ultrasound Obstet Gynecol, 55, pp.586~592 (2020)
  19. Hoffmann M, "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", Cell, 181, pp.271~280 (2020)
  20. Taglauer E, "Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15COVID-19 positive maternal-fetal dyads", Placenta, 100, pp.69~74 (2020)
  21. Bloise E, "Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia", Am J Obstet Gynecol, 224, pp.298~ (2021)
  22. Faure-Bardon V, "Protein expression of angiotensin-converting enzyme 2, a SARS-CoV-2-specific receptor, in fetal and placental tissues throughout gestation : new insight for perinatal counseling", Ultrasound Obstet Gynecol, 57, pp.242~247 (2021)
  23. Agostinis C, "SARS-CoV-2 modulates virus receptor expression in placenta and can induce trophoblast fusion, inflammation and endothelial permeability", Front Immunol, 13, pp.957224~ (2022)
  24. Argueta LB, "Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy", iScience, 25, pp.104223~ (2022)
  25. Robert-Gangneux F, "The placenta : a main role in congenital toxoplasmosis?", Trends Parasitol, 27, pp.530~536 (2011)
  26. Juttukonda LJ, "Decidual immune response following COVID-19 during pregnancy varies by timing of maternal SARS-CoV-2 infection", J Reprod Immunol, 151, pp.103501~ (2022)
  27. Fatih TAS¸, "Histopathological examination of the placenta after delivery in pregnant women with COVID-19", J Health Sci Med, 5, pp.868~874 (2022)
  28. Sun QH, "IFN-γ promotes apoptosis of the uterus and placenta in pregnant rat and human cytotrophoblast cells", J Interferon Cytokine Res, 27, pp.567~578 (2007)
  29. Sheibak N, "Elevated immunoexpression of interferon-gamma in placenta tissue samples from pregnancies complicated with preeclampsia compared to the placenta previa", Pregnancy Hypertens, 22, pp.175~180 (2020)
  30. Di Girolamo R, "Placental histopathology after SARS-CoV-2 infection in pregnancy : a systematic review and meta-analysis", Am J Obstet Gynecol MFM, 3, pp.100468~ (2021)
  31. Celik E, "Placental deficiency during maternal SARS-CoV-2 infection", Placenta, 117, pp.47~56 (2022)
  32. Kotlyar AM, "Vertical transmission of coronavirus disease 2019 : a systematic review and meta-analysis", Am J Obstet Gynecol, 224, pp.35~53 (2021)
  33. Bwire GM, "Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens : a systematic review and meta-analysis", J Med Virol, 93, pp.719~725 (2021)
  34. Heerema-McKenney A, "Defense and infection of the human placenta", APMIS, 126, pp.570~588 (2018)
  35. Fenizia C, "Analysis of SARS-CoV-2 vertical transmission during pregnancy", Nat Commun, 11, pp.5128~ (2020)
  36. Vivanti AJ, "Transplacental transmission of SARS-CoV-2 infection", Nat Commun, 11, pp.3572~ (2020)
  37. Wardhana MP, "SARS-CoV-2 antibody test for the hospitalised emergency obstetric cases : useful or wasteful", New Armen Med J, 15, pp.56~63 (2021)
  38. McDonald AJ, "Anticipating the long-term neurodevelopmental impact of the COVID-19 pandemic on newborns and infants : a call for research and preventive policy", J Affect Disord Rep, 6, pp.100213~ (2021)
  39. Brum AC, "Impact of perinatal COVID on fetal and neonatal brain and neurodevelopmental outcomes", Semin Fetal Neonatal Med, 28, pp.101427~ (2023)
  40. Shook LL, "COVID-19 in pregnancy : implications for fetal brain development", Trends Mol Med, 28, pp.319~330 (2022)

관련 논문AI추천

Placental Histopathology in COVID-19- Positive MothersJaiswal Jyoti, Khandwal Onkar, Nagaria Tripti, Neral Arvind, Sherwani Nikita, Singh Neha한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2022 · 제32권 제9호Effect of severe acute respiratory syndrome coronavirus 2 infection during pregnancy in K18-hACE2 transgenic mice김병석, 김영봉, 박기훈, 황세미, Choi Youngsok, Kim Hyoukjung, Lee Giwan, Lee Ok-Hee, Lee Siyoung아세아·태평양축산학회 · Animal Bioscience2023 · 제36권 제1호Chronic Placental Inflammation in Twin Pregnancies김연미, 김정선, 노정래, 박하영, 방희진, 배고은, 오수영, 최석주대한병리학회 · Journal of Pathology and Translational Medicine2015 · 제49권 제6호Effects of IFN-γ on IL-18 Expression in Pregnant Rats and Pregnancy OutcomesChun-sheng Gao, Jin Zhao, Li-fang Si, Shou-Yan Zhang, Shu-lin Chen, Xiang-chao Cheng아세아·태평양축산학회 · Animal Bioscience2013 · 제26권 제10호Acute Atherosis of the Uterine Spiral Arteries: Clinicopathologic Implications김연미, 김주연대한병리학회 · Journal of Pathology and Translational Medicine2015 · 제49권 제6호Pathologic Differences between Placentas from Intrauterine Growth Restriction Pregnancies with and without Absent or Reversed End Diastolic Velocity of Umbilical Arteries유진영, 유창영, 장동규, 조윤성, 이귀세라대한병리학회 · Journal of Pathology and Translational Medicine2011 · 제45권 제1호

이 간행물의 다른 논문 (7건)